Monitor
Quote
Charts
Trades
News
Financials
Toplists
Alerts
Portfolio
Level 2
Free BB
PBB
14/10/2008
03:45:26
Site map
<a href="http://as1.advfn.com/oasis/oasisc.php?s=536&w=468&h=60&ord=1223952326&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=536&w=468&h=60&ord=1223952326&t=_blank" border='0' width='468' height='60'></a>
Help
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2218&w=120&h=30&ord=1223952326&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2218&w=120&h=30&ord=1223952326&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2730&w=120&h=30&ord=1223952326&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2730&w=120&h=30&ord=1223952326&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=879&w=120&h=30&ord=1223952326&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=879&w=120&h=30&ord=1223952326&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=3376&w=120&h=30&ord=1223952326&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=3376&w=120&h=30&ord=1223952326&t=_blank" border='0' width='120' height='30'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2188&w=120&h=30&ord=1223952326&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2188&w=120&h=30&ord=1223952326&t=_blank" border='0' width='120' height='30'></a>
Abraxis Bioscience News
(NASDAQ:ABBI)
Abraxis Bioscience stock quote
|
Abraxis Bioscience company information
|
Abraxis Bioscience Stock Chart
Latest Abraxis Bioscience News Headlines
Date
Time
Source
Headline
05/06/2007
01:33
PRNUS
New Data Shows Promising Antitumor Activity with nab-paclitaxel (ABRAXANE(R)) in Combination and as a Single Agent for the Treat
Results Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting HOUSTON, June 4 /PRNewswire/ -- Leading cancer researchers affiliated with the US Oncology Research Network, one of the nation's largest cancer treatment and research networks focused on cancer treatment and research, and Abraxis BioScience...
More...>>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2216&w=120&h=600&ord=1223952326&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2216&w=120&h=600&ord=1223952326&t=_blank" border='0' width='120' height='600'></a>
<a href="http://as1.advfn.com/oasis/oasisc.php?s=2397&w=728&h=90&ord=1223952326&t=_blank" target="_blank" rel='nofollow'> <img src="http://as1.advfn.com/oasis/oasisi.php?s=2397&w=728&h=90&ord=1223952326&t=_blank" border='0' width='728' height='90'></a>
LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's
Terms & Conditions
::
Contact Us
::
Request an Exchange
::
Affiliate Scheme
Copyright1999-2008 ADVFN PLC.
Copyright and limited reproduction
::
Privacy Policy
::
Investment Warning
::
Advertise with us
::
Data accreditations
:: ::
Press office
::
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
32 site:2gb nasdaq abbi081014 03:45